MYC amplifies mitotic perturbations elicited by LXY18 to enable synthetic lethality
Authors:
Preprint
Abstract
The MYC oncoprotein represents an intriguing target for cancer treatment, but its therapeutic potential has been hindered by the absence of specific pharmacological inhibitors. In this study, we demonstrate that the phenoxy quinoline compound LXY18 selectively targets and eliminates cells overexpressing MYC, leaving non-transformed cells unharmed. This synthetic lethality arises from an acute induction of multipolarity, resulting in a persistent arrest in early mitosis followed by cell death in mitosis or after mitotic slippage. Distinctively, LXY18’s action contrasts with other antimitotic compounds, as they either fail to induce mitotic arrest or elicit mitotic arrest irrespective of MYC abundance. Furthermore, the MYC abundance in a panel of 98 tumor cell lines correlates with their sensitivity to LXY18. Collectively, our findings uncover LXY18 as an MYC- enabled mitotic blocker and open a new avenue to selectively target MYC-overexpressing tumor cells without affecting normal cells.Keywords
This publication has 29 references indexed in Scilit:
- MYC and the Control of ApoptosisCold Spring Harbor Perspectives in Medicine, 2014
- An Overview of MYC and Its InteractomeCold Spring Harbor Perspectives in Medicine, 2014
- Self-assembly and sorting of acentrosomal microtubules by TACC3 facilitate kinetochore capture during the mitotic spindle assemblyProceedings of the National Academy of Sciences, 2013
- MYC on the Path to CancerCell, 2012
- Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinaseProceedings of the National Academy of Sciences, 2010
- Inhibition of CDK1 as a potential therapy for tumors over-expressing MYCNature Medicine, 2007
- Centrosome biogenesis and function: centrosomics brings new understandingNature Reviews Molecular Cell Biology, 2007
- c-MYC Delays Prometaphase by Direct Transactivation of MAD2 and BubR1: Identification of Mechanisms Underlying c-MYC-Induced DNA Damage and Chromosomal InstabilityCell Cycle, 2007
- Genomic targets of the human c-Myc proteinGenes & Development, 2003
- Coexisting Amplifications of the Chromosome 1p32 Genes (PTPRF and MYCL1) Encoding Protein Tyrosine Phosphatase LAR and L-myc in a Small Cell Lung Cancer LineGenomics, 1995